ADVISE II: functional assessment of coronary lesions without adenosine

The pressure ratio in the resting phase of the cardiac cycle is a newly Introduced procedure for the assessment of coronary stenoses based on pressure measurement without adenosine. It generated interest with over 1500 comparisons with the FFR since its introduction at TCT 2011. The discrepancies between the two methods have been attributed to the retrospective design, different algorithms for measuring IFR failure electrocardiogram to determine the period without waves, etc. It took a rigorous prospective study to establish the clinical value of the iFR. 

Patients were treated according to iFR and FFR value. If the IFR was <0.85, they were treated; with a value between 0.86 and 0.93, they underwent FFR to decide and, with a value >0.94, they were not treated. The pressure ratio in the resting phase of the cardiac cycle (iFR) is a newly introduced procedure for the assessment of coronary stenoses based on pressure measurement without adenosine. It generated interest with over 1500 comparisons with the FFR since its introduction at TCT 2011. The discrepancies between the two methods have been attributed to the retrospective design, different algorithms for measuring iFR, electrocardiogram failure to determine the period without waves, etc. It took a rigorous prospective study to establish the clinical value of the iFR. Patients were treated according to iFR and FFR value. If the IFR was <0.85, they were treated; with a value between 0.86 and 0.93, they underwent FFR to decide and, with a value >0.94, they were not treated. Included for analysis were 308 patients with 354 stenoses. The best cutoff point for the iFR turned out to be 0.89 with a specificity of 87.5%, sensitivity of 72.2%, positive predictive value of 78% and negative predictive value of 83.7%. The hybrid approach (iFR / FFR) increased the sensitivity, specificity and positive and negative predictive value of the method (94.8%, 86.1%, 91.1% and 91.7% respectively).

Conclusions: iFR appropriately classifies stenoses in 88.2% of lesions between the values of 0.85 and 0.94. The optimal cutoff for the iFR to identify lesions with FFR <0.8 was 0.89.

Javier Escaned.
2013-05-23

Original title: Adenosine vasodilator independent stenosis evaluation II (ADVISE II). 

More articles by this author

Coronary obstruction registry after TAVI

There is little information in the literature about the obstruction of the coronary ostia after percutaneous aortic valve implantation. 81 TAVI sites and programs...

Clinical results of TAVI in Asia

Since all the studies available in the literature were conducted in North America or Europe, the results of percutaneous aortic valve replacement in Asia...

RIPCORD study: FFR changes clinical consideration of chest pain

The objective of this study was to evaluate whether routine use of FFR in all the coronary arteries could change the strategy in stable...

Coherex Wave Crest: New device for atrial appendage closure

Appendage closure devices have emerged as an alternative to anticoagulation in fibrillated patients with a contraindication for it. The study included 63 patients with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...